Every one of those 1 sits in a single category, pharma. Coltene Holding AG is most often covered alongside BeMap, which appears in 1 of these 1 story. The tracked stories average 9 original sources each. Coltene Holding AG appears in 1 tracked Biotech story from February 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Coltene Holding AG
Every one of those 1 sits in a single category, pharma. Coltene Holding AG is most often covered alongside BeMap, which appears in 1 of these 1 story. The tracked stories average 9 original sources each. Coltene Holding AG appears in 1 tracked Biotech story from February 18, 2026.
Stories tracked
1
Sources per story
9
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Coltene Holding AG. Shared-story counts are live from our verified record — not editorial picks.
A global surge in pre-market trading on February 18, 2026, has highlighted significant gains for specialized biotech and MedTech entities. Parx Materials and Coltene Holding led the sector's movement as investors pivoted toward antimicrobial innovation and dental technology amid broader market volatility.